| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 251.65B | 248.12B | 218.93B | 208.86B | 179.75B | 173.78B |
| Gross Profit | 217.83B | 214.99B | 188.12B | 193.43B | 162.70B | 150.34B |
| EBITDA | 48.51B | 52.48B | 47.22B | 44.20B | 32.04B | 29.50B |
| Net Income | 34.52B | 30.37B | 26.39B | 24.67B | 16.66B | 15.01B |
Balance Sheet | ||||||
| Total Assets | 13.57T | 13.28T | 13.52T | 13.18T | 14.17T | 12.20T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.89T | 2.21T | 2.23T | 3.61T | 1.96T |
| Total Debt | 2.12T | 1.99T | 2.39T | 1.96T | 5.56T | 2.89T |
| Total Liabilities | 12.85T | 12.57T | 12.80T | 12.53T | 13.50T | 11.52T |
| Stockholders Equity | 715.92B | 703.74B | 716.93B | 651.62B | 670.92B | 681.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -403.43B | 0.00 | -1.64T | 1.82T | 784.53B |
| Operating Cash Flow | 0.00 | -392.13B | 0.00 | -1.63T | 1.83T | 794.76B |
| Investing Cash Flow | 0.00 | 77.68B | 144.98B | 252.14B | -170.96B | -3.59B |
| Financing Cash Flow | 0.00 | -8.12B | 49.79B | -5.20B | -8.88B | -5.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥119.10B | 8.48 | ― | 2.71% | 15.37% | 35.08% | |
72 Outperform | ¥150.42B | 8.04 | 3.68% | 2.26% | 9.34% | 20.61% | |
72 Outperform | ¥163.14B | 7.55 | ― | 2.29% | 13.93% | 54.44% | |
68 Neutral | ¥82.38B | 7.94 | ― | 2.29% | 7.97% | 20.44% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥526.69B | 10.79 | 5.53% | 2.02% | 12.96% | 44.62% | |
66 Neutral | ¥1.20T | 8.94 | 8.24% | 3.06% | 12.77% | 9.22% |